// App-Quantinova.ai

Su1914 : Unique Antimicrobial and Genetic Profiles in African Americans With Crohn's Disease Suggest Underlying Mechanistic Differences

Researchers

Presenter

  • Tanvi A. Dhere

Principal Investigators

  • Shehzad A. Saeed

  • Lee Denson

  • Raymond Cross

  • Carol J. Landers

  • Dermot P. McGovern

  • Thomas D. Walters

  • Marla Dubinsky

Medical Centers

  • Pediatrics, Emory University, Atlanta, GA

  • Hospital for Sick Children, Toronto, ON, Canada

  • University of Maryland, Baltimore, MD

  • Cedars-Sinai Medical Center, Los Angeles, CA

  • Pediatrics, CCHMC, Cincinnati, OH

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Crohn's disease

  • Inflammatory bowel disease unclassified

Biomarkers

  • Nucleotide-binding oligomerization domain-containing protein 2

  • Twist-related protein 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved